Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats

Hypertension Research

Volumn 29, Issue 1, 2006, Pages 49-56

  Hirooka, Yoshitaka ^a   Kimura, Yoshikuni ^a   Nozoe, Masatsugu ^a   Sagara, Yoji ^a   Ito, Koji ^a   Sunagawa, Kenji ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Blood pressure; Heart rate; Hypertension; Oxidative stress; Sympathetic nervous system

Indexed keywords

AMLODIPINE; CALCIUM CHANNEL BLOCKING AGENT; DIHYDROPYRIDINE DERIVATIVE; DRINKING WATER; HYDRALAZINE; NICARDIPINE; NORADRENALIN; REACTIVE OXYGEN METABOLITE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; BRAIN CORTEX; BRAIN REGION; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; DISEASE PREDISPOSITION; DRUG INFUSION; ELECTRON SPIN RESONANCE; ESSENTIAL HYPERTENSION; HYPOTHALAMUS; IN VITRO STUDY; INHIBITION KINETICS; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; SPONTANEOUSLY HYPERTENSIVE RAT; STRAIN DIFFERENCE; STROKE; SYMPATHETIC TONE; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; URINARY EXCRETION;

AMLODIPINE; ANIMALS; BLOOD PRESSURE; BRAIN CHEMISTRY; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; CISTERNA MAGNA; ELECTRON SPIN RESONANCE SPECTROSCOPY; HEART RATE; INJECTIONS; LIPID PEROXIDATION; MALE; NOREPINEPHRINE; OXIDATIVE STRESS; RATS; RATS, INBRED SHR; REACTIVE OXYGEN SPECIES; SYMPATHETIC NERVOUS SYSTEM; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 33645279018     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.49     Document Type: Article

References (62)

1. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group: Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. The Antihypertensive, and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 2002; 288: 2981-2997.
2. Julius S, Kjeldsen SE, Weber M, et al: Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial. Lancet 2004; 363: 2022-2031.
3. Furberg CD, Psaty BM, Meyer JV: Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1325-1331.
4. Pahor M, Applegate WB, Williamson JD, et al: Health outcomes associated with calcium antagonists compared with other first-line antihypertensive therapies: a meta-analysis of randomized controlled trials. Lancet 2000; 356: 1949-1954.
5. Opie LH, Yasuf S, Küber W: Current status of safety and efficacy of calcium channel blockers in cardiovascular diseases: a critical analysis based on 100 studies. Prog Cardiovasc Dis 2000; 43: 171-196.
6. Chen L, Haught WH, Yang B, Saldeen TG, Parathasarathy S, Mehta JL: Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. J Am Coll Cardiol 1997; 30: 569-575.
7. Kataoka C, Egashira K, Ishibashi M, et al: Novel anti-inflammatory actions of amlodipine in a rat model of arteriosclerosis induced by long-term inhibition of nitric oxide synthesis. Am J Physiol Heart Circ Physiol 2004; 286: H768-H774.
8. Gerzanich V, Ivanova S, van der Heijden MS, Zhou H, Simard JM: Trans-cellular proliferating cell nuclear antigen gene activation in cerebral vascular smooth muscle by endothelial oxidative injury in vivo. Arterioscler Thromb Vasc Biol 2003; 23: 2048-2054.
9. Blezer ELA, Nicolay K, Goldschmeding R, Koomans HA, Joles JA: Reduction of cerebral injury in stroke-prone spontaneously hypertensive rats by amlodipine. Eur J Pharmacol 2002; 444: 75-81.
10. Pitt B, Byington RP, Furberg CD, et al, PREVENT Investigators: Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. Circulation 2000; 102: 1503-1510.
11. Zhang X, Hintze TH: Amlodipine releases nitric oxide from canine coronary microvessels: an unexpected mechanism of action of a calcium channel-blocking agent. Circulation 1998; 97: 576-580.
12. Zhou M-S, Jaimes EA, Raij L: Inhibition of oxidative stress and improvement of endothelial function by amlodipine in angiotensin II-infused rats. Am J Hypertens 2004; 17: 167-171.
13. Mason RP, Walter MF, Trumbore MW, Olmstead EG Jr, Mason PE: Membrane antioxidant effects of the charged dihydropyridine calcium antagonist amlodipine. J Mol Cell Cardiol 1999; 31: 275-281.
14. Yamagata K, Ichinose S, Tagami M: Amlodipine and carvedilol prevent cytotoxicity in cortical neurons isolated from stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 271-282.
15. Binggeli C, Corti R, Sudano I, Luscher TF, Noll G: Effects of chronic calcium channel blockade on sympathetic nerve activity in hypertension. Hypertension 2002; 39: 892-896.
16. Fogari R, Zoppi A, Corradi L, Preti P, Malalamani GD, Mugellini A: Effects of different dihydropyridine calcium antagonists on plasma norepinephrine in essential hypertension. J Hypertens 2000; 18: 1871-1875.
17. Hamada T, Watanabe M, Kaneda T, et al: Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine. J Hypertens 1998; 16: 111-118.
18. Ishimitsu T, Kobayashi T, Honda T, et al: Protective effects of an angiotensin II receptor blocker and a long-acting calcium channel blocker against cardiovascular organ injuries in hypertensive patients. Hypertens Res 2005; 28: 351-359.
19. Soong TW, Stea A, Hodson CD, Dubel SJ, Vincent SR, Snutch TP: Structure and functional expression of a member of the low voltage-activated calcium channel family. Science 1993; 260: 1133-1136.
20. Miller RJ: Multiple calcium channels and neuronal function. Science 1987; 235: 46-52.
21. Murzenok PP, Huang BS, Leenen FHH: Sympatho-inhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertension 2000; 35: 631-636.
22. Huang BS, Leenen FHH: Sympathoinhibitory and depressor effects of amlodipine in spontaneously hypertensive rats. J Cardiovasc Pharmacol 2003; 42: 153-160.
23. Kishi T, Hirooka. Y, Kimura Y, Ito K, Shimokawa H, Takeshita A: Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357-2362.
24. Touyz RM: Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension. Hypertension 2004; 44: 248-252.
25. Ganafa AA, Walton M, Eatman D, Abukhalaf IK, Bayorh MA: Amlodipine attenuates oxidative stress-induced hypertension. Am J Hypertens 2004; 17: 743-748.
26. De Champlain J, Karas M, Nguyen P, et al: Different effects of nifedipine and amlodipine on circulating catecholamine levels in essential hypertensive patients. J Hypertens 1998; 16: 1357-1369.
27. Taddei S, Virdis A, Ghiadoni L, et al: Calcium antagonist treatment by lercanidipine prevents hyperpolarization in essential hypertension. Hypertension 2003; 41: 950-955.
28. Yavuz DG, Tugler S, Koçak H, Ozener C, Akoglu E, Akalin S: Angiotensin converting enzyme inhibition and calcium channel blockage improves cyclosporine induced glucose intolerance in rats. Transplant Proc 2004; 36: 171-174.
29. Toblli JE, Stella I, Mazza ON, Fender L, Inserra F: Different effect of losartan and amlodipine on penile structure in male spontaneously hypertensive rats. Am J Nephrol 2004; 24: 614-623.
30. G-nitro-L-arginine methyl ester-induced hypertensive rat aorta: vasoprotective effects beyond the blood pressure lowering effects of amlodipine and manidipine. Hypertens Res 2005; 28: 689-700.
31. Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A: Atorvastatin causes depressor and sympatho-inhibitory effects with upregulation of nitric oxide synthases in stroke-prone spontaneously hypertensive rats. J Hypertens 2003; 21: 379-386.
32. Ide T, Tsutsui H, Kinugawa S, et al: Mitochondrial electron transport complex I is a potential source of oxygen free radicals in the failing myocardium. Circ Res 1999; 85: 357-363.
33. Ide T, Tsutsui H, Kinugawa S, et al: Direct evidence for increased hydroxyradicals originating from superoxide in the failing myocardium. Circ Res 2000; 86: 152-157.
34. Ito K, Hirooka Y, Kishi T, et al: Rho/Rho-kinase pathway in the brainstem contributes to hypertension caused by chronic nitric oxide synthase inhibition. Hypertension 2004; 43: 156-162.
35. Kimura Y, Hirooka Y, Sagara Y, et al: Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ Res 2005; 96: 252-260.
36. Sugawara H, Tobise K, Kikuchi K: Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation. Hypertens Res 1996; 19: 223-228.
37. Lippoldt A, Kneisel U, Liebner S, et al: Structural alterations of tight junctions are associated with loss of polarity in stroke-prone spontaneously hypertensive rat blood-brain barrier endothelial cells. Brain Res 2000; 885: 251-261.
38. 2+ channels in neurons by increasing protein tyrosine phosphorylation. J Biol Chem 2002; 277: 24368-24375.
39. Tseng W-P, Lin-Shiau S-Y: Neuronal death signaling by β-bungarotoxin through the activation of the N-methyl-D-aspartate (NMDA) receptor and L-type calcium channel. Biochem Pharmacol 2003; 65: 131-142.
40. Wang R-M, Zhang Q-G, Zhang G-Y: Activation of ERK5 is mediated by N-methyl-D-aspartate receptor and L-type voltage-gated calcium channel via Src involving oxidative stress after cerebral ischemia in rat hippocampus. Neurosci Lett 2004; 357: 13-16.
41. Fukuo K, Yang J, Yasuda OO et al: Nifedipine indirectly upregulates superoxide dismutase expression in endothelial cells via vascular smooth muscle cell-dependent pathways. Circulation 2002; 106: 356-361.
42. Napoli C, Salomone S, Godfraind T, et al: 1,4-Dihydropyridine calcium channel blockers inhibit plasma and LDL oxidation and formation of oxidation-specific epitopes in the arterial wall and prolong survival in stroke-prone spontaneously hypertensive rats. Stroke 1999; 30: 1907-1915.
43. Hou X, Gobeil F, Marrache AM, et al: Increased platelet-activating factor-induced periventricular brain microvascular constriction associated with immaturity. Am J Physiol Regul Integr Comp Physiol 2003; 284: 928-935.
44. Kikugawa K, Kojima T, Yamaki S, Kosugi H: Interpretation of the thiobarbituric acid reactivity of rat liver and brain homogenates in the presence of ferric ion and ethylenediaminetetraacetic acid. Anal Biochem 1992; 202: 249-255.
45. Ohtsuki T, Matsumoto M, Suzuki K, Taniguchi N, Kamada T: Mitochondrial lipid peroxidation and superoxide dismutase in rat hypertensive target organs. Am J Physiol 1995; 268: H1418-H1421.
46. Kishi T, Hirooka Y, Ito K, Sakai K, Shimokawa H, Takeshita A: Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 2002; 39: 264-268.
47. Dampney RAL: Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323-364.
48. Pilowsky PM, Goodchild AK: Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 2002; 20: 1675-1688.
49. Higuchi S, Takeshita A, Ito N, Imaizumi T, Matsuguchi H, Nakamura M: Arterial pressure and heart rate responses to calcium channel blockers administered in the brainstem in rats. Circ Res 1985; 57: 244-251.
50. Zanzinger J: Mechanisms of action of nitric oxide in the brain stem. Auton Neurosci 2002; 98: 24-27.
51. Patel KP, Li Y-F, Hirooka Y: Role of nitric oxide in central sympathetic outflow. Exp Biol Med 2001; 226: 814-824.
52. Hirooka Y, Sakai K, Kishi T, Ito K, Shimokawa H, Takeshita A: Enhanced depressor response to endothelial nitric oxide synthase gene transfer into the nucleus tractus solitarii of spontaneously hypertensive rats. Hypertens Res 2003; 26: 325-331.
53. Berkels R, Taubert D, Bartels H, Bretenbach T, Klaus W, Roesen R: Amlodipine increases endothelial nitric oxide by dual mechanisms. Pharmacology 2004; 70: 39-45.
54. Umemoto S, Tanaka M, Kawahara S, et al: Calcium antagonist reduces oxidative stress by upregulating Cu/Zn superoxide dismutase in stroke-prone spontaneously hypertensive rats. Hypertens Res 2004; 27: 877-885.
55. Kerr S, Brosnan J, McIntyre M, Reid JL, Domniczak AF, Hamilton CA: Superoxide anion production is increased in a model of genetic hypertension. Hypertension 1999; 33: 1353-1358.
56. Kimoto-Kinoshita S, Nishida S, Tomura TT: Age-related change of anti-oxidant capacities in the cerebral cortex and hippocampus of stroke-prone spontaneously hypertensive rats. Neurosci Lett 1999; 273: 41-44.
57. Wilson SK: Role of oxygen-derived free radicals in acute angiotensin II-induced hypertensive vascular disease in the rat. Circ Res 1990; 66: 722-734.
58. Zhang XM, Ellis EF: Superoxide dismutase reduces permeability and edema induced by hypertension in rats. Am J Physiol 1990; 259: H497-H503.
59. Grunfeld S, Hamilton CA, Mesaros S, et al: Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995; 26: 854-857.
60. Spence JD: Preventing dementia by treating hypertension and preventing stroke. Hypertension 2004; 44: 20-21.
61. 2+ channels by amlodipine. Br J Pharmacol 1997; 121: 1136-1140.
62. 2+ channels. Eur J Pharmacol 1999; 373: 93-100.